The US FDA is trying to secure supplies of ifosfamide, a cancer treatment in short supply due to manufacturing disruptions. IDMA is gathering information on potential Indian suppliers to address the ongoing drug shortage in the US.
US FDA sends SOS to Indian drugmakers for critical cancer medicine amid US shortage
